Craniopharyngiomas (CPs) are clinically aggressive tumors because of their invasive
behavior and recalcitrant tendency to recur after therapy. There are 2 types based on their …

BRAF mutations have been identified as targetable, oncogenic mutations in many cancers.
Given the paucity of treatments for primary brain tumors and the poor prognosis associated …

Background Craniopharyngiomas, primary brain tumors of the pituitary–hypothalamic axis,
can cause clinically significant sequelae. Treatment with the use of surgery, radiation, or …

Craniopharyngiomas are rare embryonic malformational tumors of the sellar/parasellar
region, classified by the World Health Organization (WHO) as tumors with low-grade …

Papillary craniopharyngiomas (PCPs) are characterized by the presence of BRAF V600E
mutations, which are emerging as a useful guide for diagnosis and treatment decision …

Craniopharyngioma is an intracranial congenital epithelial tumor growing along the pathway
of the embryonic craniopharyngeal tube. The main clinical symptoms of patients with …

Craniopharyngiomas (CPs) are rare primary brain epithelial tumors arising in the suprasellar
region from remnants of Rathke's pouch. About 50% originate at the level of the third …

Introduction: Childhood-onset craniopharyngiomas are rare embryonic tumors of low-grade
histological malignancy. Severe obesity, physical fatigue, and psychosocial deficits due to …

Background Surgical and clinical management of craniopharyngiomas is associated with
high long-term morbidity especially in the case of hypothalamic involvement. Improvements …

Background. Childhood and adult-onset craniopharyngioma is a rare embryogenic tumor of
the sellar, suprasellar, and parasellar region. Survival rates are high; however, tumor …